COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

31,669 Articles (22,913 medRxiv, 8,756 bioRxiv)

Most recent first Previous |  Page 1459: Articles 14581-14590  | Next

Rapid determination of the wide dynamic range of SARS-CoV-2 Spike T cell responses in whole blood of vaccinated and naturally infected
Tan, A. T., Lim, J. M., Le Bert, N., Kunasegaran, K., Chia, A., Qui, M., Tan, N., Chia, W. N., Alwis, R., Ding, Y., Ooi, E. E., Wang, L.-F., Chen, M. I., Young, B., Hsu, L. Y., Low, J., Lye, D., Bertoletti, A.
10.1101/2021.06.29.450293 — Posted: 2021-06-29
Systematic genome-scale identification of host factors for SARS-CoV-2 infection across models yields a core single gene dependency; ACE2
Chan, K., Farias, A. G., Lee, H., Guvenc, F., Mero, P., Aulakh, K., Brown, K. R., Haider, S., Marcon, E., Braunschweig, U., Tong, A. H. Y., Pu, S., Habsid, A., Christie-Holmes, N., Budylowski, P., Astori, A., Ghalami, A., Mubareka, S., Banerjee, A., Mossman, K. L., Greenblatt, J., Gray-Owen, S. D., Raught, B., Blencowe, B., Taiplale, M., Moffat, J.
10.1101/2021.06.28.450244 — Posted: 2021-06-29
Assessment of COVID-19 vaccine hesitancy among Zimbabweans: A rapid national survey
Mundagowa, P. T., Tozivepi, S. N., Chiyaka, E. T., Mukora-Mutseyekwa, F., Makurumidze, R.
10.1101/2021.06.24.21259505 — Posted: 2021-06-29
Japanese Project for Telepsychiatry Evaluation during COVID-19: Treatment Comparison Trial (J-PROTECT): Rationale, design, and methodology
Kishimoto, T., Kinoshita, S., Bun, S., Sato, Y., Kitazawa, M., Kikuchi, T., Sado, M., Takamiya, A., Mimura, M., Nakamae, T., Abe, Y., Kanazawa, T., Kawabata, Y., Tomita, H., Abe, K., Hishimoto, A., Asami, T., Suda, A., Watanabe, Y., Amagai, T., Sakuma, K., Kida, H., Funayama, M., Kimura, H., Sato, A., Fujiwara, S., Nagao, K., Sugiyama, N., Takamiya, M., Kodama, H., Azekawa, T.
10.1101/2021.06.23.21259366 — Posted: 2021-06-29
Tracking SARS-CoV-2 in rivers as a tool for epidemiological surveillance
Maidana-Kulesza, M. N., Poma, H. R., Sanguino-Jorquera, D. G., Reyes, S. I., Said-Adamo, M. d. M., Remis, M. M., Gutierrez-Cacciabue, D., Cristobal, H. A., Cruz, M. C., Gonzalez, M. A., Rajal, V. B.
10.1101/2021.06.17.21259122 — Posted: 2021-06-29
Accuracy of telephone triage for predicting adverse outcome in suspected COVID-19: An observational cohort study
Marincowitz, C., Stone, T., Bath, P., Richard Campbell, R., Turner, J., Hussein, M., Pilbery, R., Thomas, B., Sutton, L., Bell, F., Biggs, K., Hopfgartner, F., Mazumdar, S., Petrie, J., Goodacre, S.
10.1101/2021.06.24.21259441 — Posted: 2021-06-29
DEVELOPMENT AND VALIDATION OF AN ENZYME-LINKED IMMUNOASSAY KIT FOR DIAGNOSIS AND SURVEILLANCE OF COVID-19
Bagno, F. F., Sergio, S. A. R., Figueiredo, M. M., Godoi, L. C., Andrade, L. A. F., Salazar, N. C., Soares, C. P., Aguiar, A., Almeida, F. J., da Silva, E. D., Ferreira, A. G. P., Durigon, E. L., Gazzinelli, R. T., Teixeira, S. M. R., Fernandes, A. P. S. M., da Fonseca, F. G.
10.1101/2021.06.23.21259392 — Posted: 2021-06-29
Characterizing Long COVID: Deep Phenotype of a Complex Condition
Deer, R. R., Rock, M. A., Vasilevsky, N., Carmody, L. C., Rando, H. M., Anzalone, A. J., Callahan, T. J., Bramante, C. T., Chute, C. G., Greene, C. S., Gagnier, J. J., Chu, H., Koraishy, F. M., Liang, C., Liu, F., Madlock-Brown, C. R., Mazzotti, D. R., McNair, D. S., Parker, A. M., Coleman, B. D., Davis, H. E., Perry, M. A., Reese, J. T., Saltz, J. H., Solomonides, A. E., Sule, A. A., Stein, G. S., Kohler, S., Monteith, T. S., Madhira, V., Kimble, W. D., Kavuluru, R., Hillegass, W. B., Chan, L. E., Byrd, J. B., Boudreau, E. A., Liu, H., McMurry, J. A., Pfaff, E. R., Matentzoglu, N., Relevo, R., Moffitt, R. A., Schuff, R. A., Solway, J., Spratt, H., Bergquist, T., Bennett, T. D., Basson, M. D., Topaloglu, U., Wang, L., Haendel, M. A., Robinson, P. N.
10.1101/2021.06.23.21259416 — Posted: 2021-06-29
Sequencing SARS-CoV-2 Genomes from Saliva
Alpert, T., Vogels, C. B. F., Breban, M. I., Petrone, M., Yale IMPACT Research Team, , Wyllie, A. L., Grubaugh, N., Fauver, J. R.
10.1101/2021.06.21.21259289 — Posted: 2021-06-29
A bifluorescent-based assay for the identification of neutralizing antibodies against SARS-CoV-2 variants of concern in vitro and in vivo
Chiem, K., Vasquez, D. M., Silvas, J., Park, J.-G., Piepenbrink, M., Sourimant, J., Lin, M. J., Greninger, A. L., Plemper, R. K., Torrelles, J. B., Walter, M. R., de la Torre, J. C., Kobie, J., Martinez-Sobrido, L.
10.1101/2021.06.28.450214 — Posted: 2021-06-28

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).